Andrew Sikora

SaberGel, a Multimodal Delivery System for the Treatment of Oral Cancer

National Institute of Dental and Craniofacial Research · R01

PI · $679.3K · Rice University

Targeting Head and Neck Cancer Cells and the Adverse Tumor Microenvironment with a Novel Small-Molecule STAT3 Inhibitor

National Cancer Institute · R01

PI · $2.4M · University of Tx Md Anderson Can Ctr

Functional Roles of GOF TP53 Mutations in Metastasis and Immunosuppression of Head and Neck Cancers

National Institute of Dental and Craniofacial Research · R01

PI · $2.8M · University of Tx Md Anderson Can Ctr

Targeting the Immunosuppressive Tumor Microenvironment to Enhance Efficacy of Radiotherapy and Immuno-Radiotherapy for Oral Cancer

National Institute of Dental and Craniofacial Research · U01

Contact PI · $3.9M · University of Tx Md Anderson Can Ctr

Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck

Principal investigator · Withdrawn · Early phase 1

M.D. Anderson Cancer Center

Optical Imaging of Head and Neck Cancer

Principal investigator · Terminated

Sharmila Anandasabapathy, MD

Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy

Principal investigator · Completed

Icahn School of Medicine at Mount Sinai

Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium

Principal investigator · Completed

Icahn School of Medicine at Mount Sinai